Effects on platelet function of an EP3 receptor antagonist used alone and in combination with a P2Y 12 antagonist both in-vitro and ex-vivo in human volunteers

By Fox S.C.  

Platelets, Vol. 24, Iss. 5, 2013-08 ,pp. : 392-400

Informa Healthcare

Access to resources Recommend Favorite

P2Y12 Inhibitors: Pharmacologic Mechanism and Clinical Relevance

By  

Cardiovascular & Hematological Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Cardiovascular & Hematological Agents), Vol. 11, Iss. 2, 2013-06 ,pp. : 101-105

Bentham Science Publishers

Access to resources Recommend Favorite

Effects of VerifyNow P2Y12 test and CYP2C19*2 testing on clinical outcomes of patients with cardiovascular disease: A systematic review and meta-analysis

By Yamaguchi Yusuke  

Platelets, Vol. 24, Iss. 5, 2013-08 ,pp. : 352-361

Informa Healthcare

Access to resources Recommend Favorite

Emerging P2Y12 Receptor Antagonists: Role in Coronary Artery Disease

By  

Current Vascular Pharmacology, Vol. 8, Iss. 1, 2010-01 ,pp. : 93-101

Bentham Science Publishers

Access to resources Recommend Favorite

P2Y12 Receptor Antagonists in Acute Coronary Syndrome: Clinical Implications of Pharmacologic and Pharmacogenetic Differences

By  

Recent Patents on Cardiovascular Drug Discovery, Vol. 6, Iss. 3, 2011-09 ,pp. : 207-214

Bentham Science Publishers

Access to resources Recommend Favorite